Enzyme-activated anti-tumor prodrug compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C530S402000, C435S023000, C435S218000, C435S226000, C424S001530, C424S009100, C424S193100

Reexamination Certificate

active

06855689

ABSTRACT:
Disclosed are enzyme-activated anti-tumor and anti-metastatic prodrug compounds. The specific enzymes are collagenase(IV) and elastase. Also disclosed are methods of making and using such compounds.

REFERENCES:
patent: 4703107 (1987-10-01), Monsigny et al.
patent: 0 255 341 (1988-02-01), None
patent: 0 624 377 (1994-11-01), None
patent: WO 9712624 (1997-04-01), None
patent: WO 9714416 (1997-04-01), None
patent: WO 9745117 (1997-12-01), None
patent: WO 9804277 (1998-02-01), None
patent: WO 9813059 (1998-04-01), None
patent: WO 0033888 (2000-06-01), None
patent: WO 0064486 (2000-11-01), None
Hilpert et al., Characterization and Optimizing Protease/Peptide Inhibitor Interactions, a New Application for Spot Synthesis. J. Biochem. 128, 1051-1057 (2000).*
Intll Search Report for PCT/US00/10327.
Park, John E. et al; Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts, Journal of Biological Chemistry, Dec. 17, 1999, pp. 36505-36512, vol. 274, No. 51.
Calieti, P. et al; Preparation and Properties of Monomethoxy Poly(Ethylene Glycol) Doxorubicin Conjugates Linked by an Amino Acid or a Peptide as Spacer, 2193 II Farmaco, 48 (1993) Jul., No. 7, Rom, It. pp 919-932.
International Search Report-PCT/EP 00/04261.
Starcher, Barry et al; Inhibition of Neutrophil Elastase Suppresses the Development of Skin Tumors in Hairless Mice; Journal of Investigative Dermatology, (1996), vol. 107:159-163.
Hendrix, Mary J.C., et al; Expression of Type IV Collagenase Correlates with the Invasion of Human Lymphoblastoid Cells Lines and Pathogenesis in SCID Mice; Molecular and Cellular Probes (1992) 6, 59-65.
De Marre, Anne, et al; Synthesis and Evaluation of Macromolecular Prodrugs of Mitomycin C; Journal of Controlled Release 36 (1995) 87-97.
Fidler, Isaiah J.; Critical Factors in the Biology of Human Cancer Metastasis: Twenty Eight G.H.A. Clowes Memorial Award Lecture, Cancer Research 50, 6130-6138, Oct. 1, 1990.
McGuire, W, et.al., The New England Journal of Medicine, vol. 320, No. 8, pp 525-527 1989.
D. Theodorescu, et al; Dominance of Metastatically Competent Cells in Primary Murine Breast Neoplasms is Necessary for Distant Metastatic Spread, Int. J. Cancer; 47, 118-123, (1991).
Saiki, Ikuo; Antiadhesion Peptides in the Prevention of Tumour Metastasis, Disease Treatment Review, Clin. Immunother.1 (4) 1994 307-318.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enzyme-activated anti-tumor prodrug compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzyme-activated anti-tumor prodrug compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme-activated anti-tumor prodrug compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3463542

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.